A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

出版年份 2017 全文链接

标题

作者

关键词

出版物

Volume 35, Issue 4_suppl, Pages 410-410

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2017-03-22

DOI

10.1200/jco.2017.35.4_suppl.410

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now